Drug interactions between Orthoclone OKT3 and Stivarga
|Orthoclone OKT3 (muromonab-cd3)|
Interactions between your drugs
There were no interactions found in our database between Orthoclone OKT3 and Stivarga - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Orthoclone OKT3 is in the drug class selective immunosuppressants.
- Orthoclone OKT3 is used to treat the following conditions:
- Stivarga is a member of the following drug classes: multikinase inhibitors, VEGF/VEGFR inhibitors.
- Stivarga is used to treat the following conditions:
Drug and food interactions
Applies to: Stivarga (regorafenib)
Depending on the amount of fat, food may help the absorption of regorafenib. You should take it with a low-fat breakfast at the same time everyday to maintain consistent blood levels and effects. Examples of a low-fat breakfast include: 2 slices of white toast with 1 tablespoon of low-fat margarine and 1 tablespoon of jelly, plus 8 ounces of skim milk (319 calories; 8.2 g fat); or 1 cup of cereal, 8 ounces of skim milk, 1 slice of toast with jam, apple juice, and 1 cup of coffee or tea (520 calories; 2 g fat). Avoid consuming grapefruit or grapefruit juice during treatment, as it may alter the blood levels and effects of the medication. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|